Target intelligence / Profile preview

DNA primase and DNA ligase

Molecular classification
Enzyme
01

Overview

DNA primase and DNA ligase are two distinct classes of enzymes essential for the maintenance and replication of the genome (PubMed 27535915). DNA primase, typically functioning within the DNA polymerase alpha-primase complex, is responsible for synthesizing short RNA primers that provide the essential 3'-OH group required for DNA polymerases to initiate synthesis, particularly on the lagging strand (UniProt P49642). DNA ligase subsequently seals the nicks between DNA fragments, such as Okazaki fragments, by catalyzing the formation of phosphodiester bonds between the 3'-hydroxyl and 5'-phosphate ends (UniProt P18858). While both are critical components of the replisome and are investigated as therapeutic targets in oncology and infectious diseases, they are separate proteins with unique catalytic mechanisms (PubMed 30249624). Inhibiting these enzymes leads to stalled replication forks, DNA double-strand breaks, and ultimately cell death, making them attractive for targeting rapidly dividing cancer cells or pathogens (PubMed 28910176). This target entry is considered incorrect as it conflates two distinct enzyme families that, while functionally related in the DNA replication pathway, are encoded by different genes and possess different active sites.

Other names
DNA primaseDNA ligaseDNA replication machineryReplisome components
02

Mechanism of action

Inhibition of RNA primer synthesis (primase) and DNA strand ligation (ligase) to disrupt DNA replication and repair.

03

Biological functions

DNA replicationDNA repairCell cycle regulation
04

Disease associations

CancerInfection
05

Safety considerations

Myelosuppression (StatPearls NBK557680)Genotoxicity (PubMed 15121057)Gastrointestinal toxicityImpaired wound healing
06

Interacting drugs

Cytarabine (Ara-C) (PubChem CID 6253)

4 more in the full profile.

07

Biomarkers

PCNA (Proliferating Cell Nuclear Antigen) (PubMed 11597506)Ki-67 (PubMed 11597506)Gamma-H2AX (H2AFX) (PubMed 23507556)

Beyond the preview

Go deeper on DNA primase and DNA ligase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA primase and DNA ligase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call